ZACHARY LEVINE M.D.
Prescription History 1831401421
Internal Medicine - Infectious Disease in Rochester Hills, MI

Active since July 12, 2010PECOS EnrolledAccepts Medicare Assignment
83.35/100
CMS Quality Rating
1701 SOUTH BLVD E, SUITE 160, ROCHESTER HILLS, MI 48307(248) 598-5080 Get Directions

NPPES record last updated: October 15, 2024. Verified against the NPPES registry weekly; last sync: August 23, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ZACHARY LEVINE M.D., an active Infectious Disease specialist practicing in Rochester Hills, MI. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 60 documented patient claims. Among these therapy options, the most frequently utilized medication is Descovy, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

5
Medications
60
Total Claims
68
30-Day Fills
Descovy
Most Prescribed · 13 claims
View details
5 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by ZACHARY LEVINE M.D. in 2023, with prescription volumes, average cost per fill, and MI state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other MI PrescribersVs. MI Avg

About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2023, this provider wrote 13 Medicare prescriptions for Descovy, about a third of the volume of the typical Michigan prescriber of this medication (36). Medicare paid an average of $2,310.26 per fill, versus $2,159.42 statewide.

How often this provider prescribes it

This provider
13
MI average
36.0

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,310.26
MI average
$2,159.42

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2023

About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2023, this provider wrote 13 Medicare prescriptions for Tivicay, about a third of the volume of the typical Michigan prescriber of this medication (38). Medicare paid an average of $2,280.02 per fill, versus $2,299.00 statewide.

How often this provider prescribes it

This provider
13
MI average
38.0

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,280.02
MI average
$2,299.00

This provider's average cost per fill is below the MI average for this medication.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2023

About Cefazolin Sodium: Cefazolin is an antibiotic used to treat a wide variety of bacterial infections. Show more ▾

It may also be used before and during certain surgeries to help prevent infection. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.

In 2023, this provider wrote 12 Medicare prescriptions for Cefazolin Sodium, about half the volume of the typical Michigan prescriber of this medication (28). Medicare paid an average of $44.29 per fill, versus $50.16 statewide.

How often this provider prescribes it

This provider
12
MI average
28.0

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$44.29
MI average
$50.16

This provider's average cost per fill is below the MI average for this medication.

12
30-Day Fills
standardized to 30-day supplies
73
Days of Medication
total across all patients in 2023

About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2023, this provider wrote 11 Medicare prescriptions for Biktarvy, about 16% of the volume of the typical Michigan prescriber of this medication (68). Medicare paid an average of $4,107.32 per fill, versus $3,858.12 statewide.

How often this provider prescribes it

This provider
11
MI average
68.0

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$4,107.32
MI average
$3,858.12

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
330
Days of Medication
total across all patients in 2023

About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾

It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

In 2023, this provider wrote 11 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about half the volume of the typical Michigan prescriber of this medication (24). Medicare paid an average of $17.25 per fill, versus $4.38 statewide.

How often this provider prescribes it

This provider
11
MI average
24.0

This provider prescribes this medication less often than the average MI prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$17.25
MI average
$4.38

Gross Part D cost per fill; not the patient's out-of-pocket price.

19
30-Day Fills
standardized to 30-day supplies
533
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average MI prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MI average cost per fill.

About this data. The prescription history for ZACHARY LEVINE M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Rochester Hills, MI practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MI prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.